PROBI AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 290 SEK | +5.84% |
|
+5.84% | +42.86% |
| 10:00am | Transcript : Probi AB, Q2 2024 Earnings Call, Jul 16, 2024 | |
| 08:00am | Probi AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
Presentation Operator MessageOperator (Operator)Welcome to Probi Q2 Report 2024. [Operator Ins...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Companyâs activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Sector
Pharmaceuticals
Calendar
07:00am
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +42.86% | 295M | |
| +63.05% | 856B | |
| +39.25% | 631B | |
| -4.78% | 359B | |
| +17.52% | 325B | |
| +8.43% | 297B | |
| +13.58% | 244B | |
| +4.95% | 234B | |
| +16.20% | 226B | |
| +14.63% | 177B |
- Stock Market
- Equities
- PROB Stock
- News Probi AB
- Transcript : Probi AB, Q2 2024 Earnings Call, Jul 16, 2024
